iShares Genomics Immunology and Healthcare ETF Rating $35.07 -0.17 (-0.48%) As of 12:24 PM Eastern Add Compare Share Share Ratings Stock AnalysisChartDividendHoldingsOwnershipRatingsShort InterestBuy This Stock iShares Genomics Immunology and Healthcare ETF Aggregate Rating and Price Target (2026)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.IDNA Aggregate RatingModerate Buy 2.59Holdings in IDNA have an aggregate rating of Moderate Buy based on 275 analyst ratings issued in the past year covering 17 companies (56.7% of the portfolio).IDNA Aggregate Price Target$34.88-0.54% DownsideHigh Prediction$34.88Average Prediction$34.88Low Prediction$34.88Holdings in IDNA have an aggregate price target of $34.88 and a range of $34.88 to $34.88 covering 17 companies (56.7% of the portfolio).IDNA Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy0 Buy rating(s)Moderate Buy13 Moderate Buy rating(s)Hold3 Hold rating(s)Reduce1 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by iShares Genomics Immunology and Healthcare ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 17 IDNA Holdings ExportWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings5.66%TWSTTwist Bioscience$120.30-4.0%1.3593 of 5 stars2.70$98.30 -18.3%10Insider Trade4.66%RVMDRevolution Medicines$201.43-0.3%2.4215 of 5 stars2.91$161.79 -19.7%22Analyst Forecast4.23%MRNAModerna$63.05-1.0%1.3556 of 5 stars1.88$42.13 -33.2%174.18%REGNRegeneron Pharmaceuticals$802.20-0.5%3.78 of 5 stars2.62$793.74 -1.1%26Insider Trade3.99%INCYIncyte$119.59-0.8%3.6297 of 5 stars2.43$120.65 0.9%23Analyst ForecastGap Up3.76%VRTXVertex Pharmaceuticals$506.91-1.8%4.4301 of 5 stars2.92$563.50 11.2%243.61%MRKMerck & Co., Inc.$134.73-0.6%4.373 of 5 stars2.68$135.50 0.6%22Trending NewsAnalyst ForecastInsider TradeAnalyst Revision3.60%BNTXBioNTech$91.54-0.6%3.3454 of 5 stars2.74$127.81 39.6%193.48%EXELExelixis$50.71+0.2%3.1116 of 5 stars2.32$49.79 -1.8%19Positive NewsAnalyst UpgradeInsider Trade3.27%IDYAIDEAYA Biosciences$36.13-1.5%2.6141 of 5 stars2.81$50.13 38.7%163.06%IBRXImmunityBio$7.48-2.3%2.5042 of 5 stars2.71$14.20 90.0%72.96%CAICaris Life Sciences$21.74-2.0%4.2262 of 5 stars2.50$26.33 21.1%122.61%IOVAIovance Biotherapeutics$6.51-0.2%2.6255 of 5 stars2.33$8.00 23.0%92.55%RCUSArcus Biosciences$28.64-0.8%2.7461 of 5 stars2.58$37.80 32.0%121.73%NUVBNuvation Bio$6.02-1.4%3.7422 of 5 stars2.64$13.00 116.1%11Analyst Revision1.73%ABCLAbCellera Biologics$11.18+1.9%2.3907 of 5 stars2.71$12.83 14.8%7Analyst Forecast1.63%CRSPCRISPR Therapeutics$53.17-1.5%3.6203 of 5 stars2.58$68.06 28.0%19 This page (NYSEARCA:IDNA) was last updated on 8/14/2026 by MarketBeat.com Staff. From Our PartnersHere’s the stock symbol I’ve promisedWhitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...Stansberry Research | SponsoredTrump’s New Currency ResetTrump is launching a new $250 bill - but that may be a distraction. Behind the scenes, Executive Order 14241 i...Porter & Company | SponsoredYour $29.97 book is free todayWhy Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options ca...Profits Run | SponsoredThey didn't warn anyone in 1971. This time someone is warning you.On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...Reagan Gold Group | SponsoredBSEM Is Officially on Nasdaq... The Next Chapter Begins!BioStem Technologies (NASDAQ: BSEM) debuted on Nasdaq August 7th, marking its move from OTC markets into a new...Huge Alerts | SponsoredThe Starlink of EnergyA portable energy unit - already used by the U.S. Navy for decades - is now drawing serious attention from Big...Monument Traders Alliance | SponsoredBuffett's Final Warning: "The Dollar Is Going to Hell"The US just hit $39 trillion in debt. Interest alone is now over $1 trillion a year, more than the entire defe...Decentralized Masters | SponsoredAfter KDA, PRE, and OCEAN—this is the one17,556% on KDA. Here's what I'm buying now. It's a coin under $1.00 that most investors have never heard of...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding iShares Genomics Immunology and Healthcare ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share iShares Genomics Immunology and Healthcare ETF With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
